Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dorothea Friess"'
Autor:
Axel Rüfer, Hubert Angermann, Rudolf Benz, Nicolas Bonadies, Antonello Calderoni, Nathan Cantoni, Anna Efthymiou, Robert Escher, Geneviève Favre, Dorothea Friess, Andreas Gschwend, Andreas Himmelmann, Andreas Holbro, Peter Keller, Eirini Kouroupi, Thomas Lehmann, Nikolaus Pedarnig, Véronique Rigamonti, Kaveh Samii, Adrian Schmidt, Hans-Peter Schäfer, Roland Sperb, Georg Stüssi, Annette Winkler, Reinhard Zenhäusern, Jeroen S. Goede, on behalf of the SLIM-Registry Investigators
Publikováno v:
HemaSphere, Vol 6, Iss 7, p e741 (2022)
Externí odkaz:
https://doaj.org/article/96e57933677a4445bcd61d39ea571d5b
Autor:
Paula Fernández, Friedel Wenzel, Jan Dirks, Alexandar Tzankov, Pontus Lundberg, Dorothea Friess, Stefan Dirnhofer, Thomas Menter
Publikováno v:
Pathobiology. 86:162-166
Background: RUNX1 is a crucial transcription factor for hematological stem cells and well-known for its association with acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML). Besides the translocation t(8; 21) that leads to the RUN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb43146ecfab7b0aec525fd891db16f0
https://doi.org/10.1159/000493688
https://doi.org/10.1159/000493688
Autor:
Peter M. Keller, Andrea Schmid, Kurt Leibundgut, Dorothea Friess, Beatrice U. Mueller, Behrouz Mansouri Taleghani, Gabriela M. Baerlocher, Thomas Pabst
Publikováno v:
Leukemia & lymphoma
Current practice in Switzerland for the mobilization of autologous stem cells in patients with myeloma is combining vinorelbine chemotherapy and granulocyte-colony stimulating factor (G-CSF) cytokine stimulation. We prospectively investigated adding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b12f64775e591a4b95c661bc378e6e5
Autor:
Johanna A. Kremer Hovinga, Johannes Oldenburg, Bernhard Lämmle, Dorothea Friess, Maximilian Jahns, Franziska Demarmels Biasiutti, Lorenzo Alberio, Giuseppe Colucci
Publikováno v:
Thrombosis and Haemostasis. 106:381-382
Massive muscle haematoma three months after starting vitamin K antagonist therapy for deep-vein thrombosis in an antithrombin deficient patient: Another case of factor IX propeptide mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e13a64768a12c1eb74c62d096f8b94c
https://doi.org/10.1160/th11-03-0191
https://doi.org/10.1160/th11-03-0191